←
SWOG Cancer Research Network15,026 posts
SWOG Cancer Research Network avatar✓

SWOG Cancer Research Network ✓

@SWOG

SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.

◷ Joined January 2012▧ 2,048 Photos and videos
Brendan Guercio avatar
⟳ SWOG Cancer Research Network retweeted
Brendan Guercio@BrendanGuercio·Nov 7

Thank you @SaadAtiq24 and #DAVAGU. We definitely encourage all investigators to enroll to @SWOG S2419 BioFront , the very first registrational trial to harness the #microbiome for patients with #RCC! Early trials of the MO-03 probiotic showed strong efficacy signals without added toxicity. Many thanks to @PBarataMD @drulkav @montypal @NazliDizman @djmcconkey @LauraEsfeller for leading this effort to help patients with kidney cancer.

Post attachmentPost attachment
David Gandara avatar
⟳ SWOG Cancer Research Network retweeted
David Gandara@drgandara·Sep 13

MAVERICK trial. This KM curve says it all. It's RIP for PCI in SCLC. @SWOG

Post attachment
Dr. Anthony Letai avatar
⟳ SWOG Cancer Research Network retweeted
Dr. Anthony Letai@NCIDirector·Aug 31

I am committed to reducing administrative burdens related to cancer clinical trials. NCI SBIR-funded @theMedNet is helping with TrialMatch, a new AI-assisted tool that makes it faster and easier for doctors to find trials for their patients. go.nih.gov/uA0Cyg2

Post attachment
Dr. Nagla Abdel Karim avatar
⟳ SWOG Cancer Research Network retweeted
Dr. Nagla Abdel Karim@NaglaAKarimMD·Aug 22

I can’t wait to learn about the results of #S1827 in the presidential session on the first day of #WCLC2026 @IASLC @SWOG #PCI in Limited Stage SCLC & Extensive Stage SCLC Benefits, neurotoxicity, Early detection of lesions, role of MRI & SRS all are important questions.

SWOG Cancer Research Network avatar
SWOG Cancer Research Network@SWOG·Aug 20

Ovarian reserve as measure of adjuvant chemotherapy benefit in HR-positive, HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER) In premenopausal pts <55yrs, AMH was significantly better indicator of chemo benefit than menopause status, age annalsofoncology.org/article…

Annals of Oncology avatar
⟳ SWOG Cancer Research Network retweeted
Annals of Oncology@Annals_Oncology·Jul 29

🔥Measures of ovarian reserve could help refine selection to chemotherapy for patients with HR+, HER2-neg eBC 👉In RxPONDER, among premenopausal patients aged<55, those with low AMH levels did not benefit from chemotherapy doi.org/10.1016/j.annonc.202…

Post attachment
Julie Gralow avatar
⟳ SWOG Cancer Research Network retweeted
Julie Gralow@jrgralow·Aug 15

Final day of @SWOG Latin America Initiative @incanMX @SMEOMX symposium in Precision Oncology Research, Methods, and Data symposium in Mexico City. Congrats to the students and early career researchers selected to present their clinical trials proposals for in depth review and discussion! @Betzabe100 @anelcabrera

Post attachment
Sia Daneshmand, M.D. avatar
⟳ SWOG Cancer Research Network retweeted
Sia Daneshmand, M.D.@siadaneshmand·Jul 25

New in @JAMANetworkOpen: @SWOG S1600, a multicenter phase 3 RCT, found no reduction in 30- or 90-day complications w/ specialized immunonutrition vs standard nutrition after cystectomy. Exploratory DFS/OS favored immunonutrition. #BladderCancer @JhamiltonReeves @DrJoeUnger @JMHolzbeierlein @FoxChaseCancer @BCM_Urology @JanetKukreja @eugenekanglee @URMCUrology @DrDawnHershman @fischmd @lynnhenrymd jamanetwork.com/journals/jam…

Post attachment